Case Study

Genomics England Case Study

WekaIO allows Genomics England to scale to extreme performance and capacity in their mandate to sequence 5 million genomes by 2023. Genomics England, headquartered in London, England, is owned by the UK Department of Health and Social Care to run the 5 million genomes project, announced in 2018, which aims to sequence 5 million genomes from National Health Service (NHS) patients with rare diseases.